Related Experiment Video
Updated: May 20, 2025

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Hyperkalemia in Pediatric Severe Malaria
Michael Lintner-Rivera1, Adnan Bhutta2, Ruth Namazzi3
1Department of Pediatrics, Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, Indianapolis, IN; Division of Pediatric Critical Care, Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN.
None:
Severe malaria remains an important global cause of mortality, particularly in sub-Saharan Africa, where the majority of deaths occur in children under 5 years of age. Hyperkalemia in severe malaria has not been very well reported but is associated with increased mortality. Severe malaria has several features that predispose patients to hyperkalemia, including acute kidney injury, hemolysis, metabolic acidosis, and severe anemia requiring blood transfusion. Our objective is to discuss the epidemiology of hyperkalemia in severe malaria, provide an overview of potassium homeostasis, and discuss risk factors for elevated potassium levels in severe malaria, as well as management strategies considering the resource-limited settings where malaria is endemic.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Roles of Electrolytes: Sodium and Potassium
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

